JOHN SLINGERLAND: Open Payments
NPI 1710592811 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 5 payments from 4 companies in 2025. Trend: 2023 $230 · 2024 $356 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| IBSA Pharma Inc. | 2 | $41 |
| TerSera Therapeutics LLC | 1 | $28 |
| Radius Health, Inc. | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
Products named: Tirosint, Prialt, Tymlos, Xeomin.
Industry payments across CA — which companies pay providers there.
